Article History
Received: 2 February 2021
Accepted: 21 April 2021
First Online: 16 May 2021
Change Date: 20 May 2021
Change Type: Corrigendum
Change Details: Title of table 1 was overlapped and corrected in this version.
Declarations
:
: SO and AS have no conflicts of interest to disclose. TB is supported through unrestricted research funding: Novartis, Eli Lilly Japan, Honoraria (e.g., lecture fees): Novo Nordisk, MSD, Takeda, Taisyo, Mitsubishi Tanabe, Chugai, Ono, Nippon Boehringer Ingelheim, Sumitomo Dainippon, Daiichi Sankyo, and Subsidies or Donations: Terumo, Teijin, Abbott, Sumitomo Dainippon, Ono, Nippon Boehringer Ingelheim, Baxter, Alcon, Chugai, Novo Nordisk, Nipro, MSD, Astellas, Mitsubishi Tanabe, Daiichi Sankyo, Taisyo, Bayer, Santen, Sanwa Kagaku.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki. Declaration of 1964 and later versions.